Effectiveness of a single low‐dose computed tomography screening for lung cancer: A population‐based perspective cohort study in China

Author:

Yu Zhifu1,Ni Ping1,Yu Huihui1,Zuo Tingting1,Liu Yunyong2ORCID,Wang Danbo3ORCID

Affiliation:

1. Liaoning Office for Cancer Control and Research Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute Shenyang Liaoning China

2. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen China

3. Department of Gynecology, Cancer Hospital of China Medical University Liaoning Cancer Hospital and Institute Shenyang Liaoning China

Abstract

AbstractThe purpose of this perspective cohort study was to evaluate the effectiveness of low‐dose computed tomography (LDCT) screening for lung cancer in China. This study was conducted under the China Urban Cancer Screening Program (CanSPUC). The analysis was based on participants aged 40 to 74 years from 2012 to 2019. A total of 255 569 eligible participants were recruited in the study. Among the 58 136 participants at high risk of lung cancer, 20 346 (35.00%) had a single LDCT scan (defined as the screened group) and 37 790 (65.00%) not (defined as the non‐screened group). Overall, 1162 participants were diagnosed with lung cancer at median follow‐up time of 5.25 years. The screened group had the highest cumulative incidence of lung cancer and the non‐screened group had the highest cumulative lung cancer mortality and all‐cause cumulative mortality. We performed inverse probability weighting (IPW) to account for potential imbalances, and Cox proportional hazards model to estimate the weighted association between mortality and LDCT scans. After IPW adjusted with baseline characteristics, the lung cancer incidence density was significantly increased (37.0% increase) (HR1.37 [95%CI 1.12‐1.69]), lung cancer mortality was decreased (31.0% decrease) (HR0.69 [95%CI 0.49‐0.97]), and the all‐cause mortality was significantly decreased (23.0% lower) (HR0.77 [95% CI 0.68‐0.87]) in the screened group. In summary, a single LDCT for lung cancer screening will reduce the mortality of lung cancer and all‐cause mortality in China.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Cancer incidence and mortality in China, 2016

3. Report of cancer incidence and mortality in China, 2010;Chen W;Ann Transl Med,2014

4. Report of cancer epidemiology in China, 2015;Zheng RS;Zhonghua zhong liu za zhi [Chin J Oncol],2019

5. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3